595 related articles for article (PubMed ID: 33415160)
1. Gene Alterations of N6-Methyladenosine (m
Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
[TBL] [Abstract][Full Text] [Related]
2. A Prognostic Molecular Signature of N⁶-Methyladenosine Methylation Regulators for Soft-Tissue Sarcoma from The Cancer Genome Atlas Database.
Hou M; Guo X; Chen Y; Cong L; Pan C
Med Sci Monit; 2020 Dec; 26():e928400. PubMed ID: 33370249
[TBL] [Abstract][Full Text] [Related]
3. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
Ma J; Yang D; Ma XX
Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of m6A related gene mutation characteristics and prognosis in colorectal cancer.
Jiang T; Xing L; Zhao L; Ye Z; Yu D; Lin S
BMC Med Genomics; 2023 May; 16(1):105. PubMed ID: 37194014
[TBL] [Abstract][Full Text] [Related]
5. m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.
Rønningen T; Dahl MB; Valderhaug TG; Cayir A; Keller M; Tönjes A; Blüher M; Böttcher Y
Front Endocrinol (Lausanne); 2021; 12():778875. PubMed ID: 34950106
[TBL] [Abstract][Full Text] [Related]
6. Gene signature and prognostic merit of M6a regulators in colorectal cancer.
Zhang J; Cheng X; Wang J; Huang Y; Yuan J; Guo D
Exp Biol Med (Maywood); 2020 Sep; 245(15):1344-1354. PubMed ID: 32605475
[TBL] [Abstract][Full Text] [Related]
7. m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
Zhang W; Wang L; Zhang P; Zhang Q
Medicine (Baltimore); 2021 May; 100(20):e25952. PubMed ID: 34011074
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer.
Condic M; Ralser DJ; Klümper N; Ellinger J; Qureischi M; Egger EK; Kristiansen G; Mustea A; Thiesler T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806168
[TBL] [Abstract][Full Text] [Related]
9. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
Han X; Liu J; Cheng G; Cui S
Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
[TBL] [Abstract][Full Text] [Related]
10. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
11. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
[TBL] [Abstract][Full Text] [Related]
12. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database.
Zhou J; Wang J; Hong B; Ma K; Xie H; Li L; Zhang K; Zhou B; Cai L; Gong K
Aging (Albany NY); 2019 Mar; 11(6):1633-1647. PubMed ID: 30877265
[TBL] [Abstract][Full Text] [Related]
13. Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer.
Ren S; Xiao Y; Wang H; Zhao L; Li H; Wei L; Huang Y; Liu H
Transl Cancer Res; 2023 Aug; 12(8):2033-2047. PubMed ID: 37701104
[TBL] [Abstract][Full Text] [Related]
14. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
16. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of m
Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer.
Zhao Z; Yang YB; Li XY; Li XG; Chu XD; Lin ZB; Zhang YR; Guo YG; Ding H; Pan YL; Wang L; Pan JH
Dis Markers; 2021; 2021():8686307. PubMed ID: 34745388
[TBL] [Abstract][Full Text] [Related]
19. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
[TBL] [Abstract][Full Text] [Related]
20. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
